Therapy involving diabetes drug empagliflozin shows promise in delaying hospitalizations for heart failure
About 800,000 people in the U.S. suffer a heart attack every year, and about 30% of them will go on to develop heart failure. There are limited treatments to prevent or slow that development.
Apr 8, 2024
0
0